BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Raziyeva K, Smagulova A, Kim Y, Smagul S, Nurkesh A, Saparov A. Preconditioned and Genetically Modified Stem Cells for Myocardial Infarction Treatment. Int J Mol Sci 2020;21:E7301. [PMID: 33023264 DOI: 10.3390/ijms21197301] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Castillo MG, Peralta TM, Locatelli P, Velazquez C, Herrero Y, Crottogini AJ, Olea FD, Cuniberti LA. Promoting early neovascularization by allotransplanted adipose-derived Muse cells in an ovine model of acute myocardial infarction. PLoS One 2023;18:e0277442. [PMID: 36662847 DOI: 10.1371/journal.pone.0277442] [Reference Citation Analysis]
2 Azizidoost S, Farzaneh M. MicroRNAs as a Novel Player for Differentiation of Mesenchymal Stem Cells into Cardiomyocytes. Curr Stem Cell Res Ther 2023;18:27-34. [PMID: 35466882 DOI: 10.2174/1574888X17666220422094150] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Manshori M, Kazemnejad S, Naderi N, Darzi M, Aboutaleb N, Golshahi H. Greater angiogenic and immunoregulatory potency of bFGF and 5-aza-2'-deoxycytidine pre-treated menstrual blood stem cells in compare to bone marrow stem cells in rat model of myocardial infarction. BMC Cardiovasc Disord 2022;22:578. [PMID: 36587199 DOI: 10.1186/s12872-022-03032-7] [Reference Citation Analysis]
4 Zayed MA, Sultan S, Alsaab HO, Yousof SM, Alrefaei GI, Alsubhi NH, Alkarim S, Al Ghamdi KS, Bagabir SA, Jana A, Alghamdi BS, Atta HM, Ashraf GM. Stem-Cell-Based Therapy: The Celestial Weapon against Neurological Disorders. Cells 2022;11:3476. [DOI: 10.3390/cells11213476] [Reference Citation Analysis]
5 Raman N, Imran SA, Ahmad Amin Noordin KB, Wan Kamarul Zaman WS, Nordin F. Mechanotransduction of mesenchymal stem cells (MSCs) during cardiomyocytes differentiation. Heliyon 2022. [DOI: 10.1016/j.heliyon.2022.e11624] [Reference Citation Analysis]
6 Sarsenova M, Kim Y, Raziyeva K, Kazybay B, Ogay V, Saparov A. Recent advances to enhance the immunomodulatory potential of mesenchymal stem cells. Front Immunol 2022;13:1010399. [DOI: 10.3389/fimmu.2022.1010399] [Reference Citation Analysis]
7 Raziyeva K, Kim Y, Zharkinbekov Z, Temirkhanova K, Saparov A. Novel Therapies for the Treatment of Cardiac Fibrosis Following Myocardial Infarction. Biomedicines 2022;10:2178. [DOI: 10.3390/biomedicines10092178] [Reference Citation Analysis]
8 Zhao L, Wang L, Zhang W, Wang R, Zhang X, Lei X, Liang Y, Song Y, Zhang Q, Lin K, Xie H. Promotion of right ventricular outflow tract reconstruction using a novel cardiac patch incorporated with hypoxia-pretreated urine-derived stem cells. Bioactive Materials 2022;14:206-18. [DOI: 10.1016/j.bioactmat.2021.11.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Handley EL, Callanan A. Modulation of Tissue Microenvironment Following Myocardial Infarction. Advanced NanoBiomed Research. [DOI: 10.1002/anbr.202200005] [Reference Citation Analysis]
10 Matta A, Nader V, Lebrin M, Gross F, Prats A, Cussac D, Galinier M, Roncalli J. Pre-Conditioning Methods and Novel Approaches with Mesenchymal Stem Cells Therapy in Cardiovascular Disease. Cells 2022;11:1620. [DOI: 10.3390/cells11101620] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
11 Silva IGRD, Pantoja BTDS, Almeida GHDR, Carreira ACO, Miglino MA. Bacterial Cellulose and ECM Hydrogels: An Innovative Approach for Cardiovascular Regenerative Medicine. IJMS 2022;23:3955. [DOI: 10.3390/ijms23073955] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Chen G, Liang X, Han Q, Mai C, Shi L, Shao Z, Hong Y, Lin F, Li M, Hu B, Li X, Zhang Y. Apelin-13 Pretreatment Promotes the Cardioprotective Effect of Mesenchymal Stem Cells against Myocardial Infarction by Improving Their Survival. Stem Cells Int 2022;2022:3742678. [PMID: 35355588 DOI: 10.1155/2022/3742678] [Reference Citation Analysis]
13 Zhang Q, Wang L, Wang S, Cheng H, Xu L, Pei G, Wang Y, Fu C, Jiang Y, He C, Wei Q. Signaling pathways and targeted therapy for myocardial infarction. Signal Transduct Target Ther 2022;7:78. [PMID: 35273164 DOI: 10.1038/s41392-022-00925-z] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 37.0] [Reference Citation Analysis]
14 He M, Cheng K. Nanoparticle and microparticle delivery in RNA-based cardiovascular disease treatment. Reference Module in Materials Science and Materials Engineering 2022. [DOI: 10.1016/b978-0-12-822425-0.00074-9] [Reference Citation Analysis]
15 Carr NJ. The pathology of healing and repair. Surgery (Oxford) 2022;40:13-9. [DOI: 10.1016/j.mpsur.2021.11.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Sedlakova V, Ahumada M, Suuronen EJ, Alarcon EI. Building new cardiac vasculature and myocardium: where are we at? Curr Opin Cardiol 2021;36:728-34. [PMID: 34456252 DOI: 10.1097/HCO.0000000000000905] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Sarsenova M, Issabekova A, Abisheva S, Rutskaya-Moroshan K, Ogay V, Saparov A. Mesenchymal Stem Cell-Based Therapy for Rheumatoid Arthritis. Int J Mol Sci 2021;22:11592. [PMID: 34769021 DOI: 10.3390/ijms222111592] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
18 Chen M, Chen J, Li C, Yu R, Chen W, Chen C. Improvement of cardiac function by mesenchymal stem cells derived extracellular vesicles through targeting miR-497/Smad7 axis. Aging (Albany NY) 2021;13:22276-85. [PMID: 34528899 DOI: 10.18632/aging.203533] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
19 Kim Y, Zharkinbekov Z, Sarsenova M, Yeltay G, Saparov A. Recent Advances in Gene Therapy for Cardiac Tissue Regeneration. Int J Mol Sci 2021;22:9206. [PMID: 34502115 DOI: 10.3390/ijms22179206] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
20 Chingale M, Zhu D, Cheng K, Huang K. Bioengineering Technologies for Cardiac Regenerative Medicine. Front Bioeng Biotechnol 2021;9:681705. [PMID: 34150737 DOI: 10.3389/fbioe.2021.681705] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
21 Raziyeva K, Kim Y, Zharkinbekov Z, Kassymbek K, Jimi S, Saparov A. Immunology of Acute and Chronic Wound Healing. Biomolecules 2021;11:700. [PMID: 34066746 DOI: 10.3390/biom11050700] [Cited by in Crossref: 62] [Cited by in F6Publishing: 72] [Article Influence: 31.0] [Reference Citation Analysis]
22 Crippa S, Santi L, Berti M, De Ponti G, Bernardo ME. Role of ex vivo Expanded Mesenchymal Stromal Cells in Determining Hematopoietic Stem Cell Transplantation Outcome. Front Cell Dev Biol 2021;9:663316. [PMID: 34017834 DOI: 10.3389/fcell.2021.663316] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
23 Madeddu P. Cell therapy for the treatment of heart disease: Renovation work on the broken heart is still in progress. Free Radic Biol Med 2021;164:206-22. [PMID: 33421587 DOI: 10.1016/j.freeradbiomed.2020.12.444] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]